Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension

By Chrysant Steven G.   Murray Alexander V.   Hoppe Uta C.   Dattani Dan   Patel Samir   Ritter Shannon   Zhang Jack  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2841-2849

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

By Littlejohn Thomas W.   Trenkwalder Peter   Hollanders Geert   Zhao Yanxing   Liao Weichi  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 951-959

Informa Healthcare

Access to resources Recommend Favorite

Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension

By Calhoun David A.   Glazer Robert D.   Pettyjohn Frank S.   Coenen P. D. M.   Zhao Yanxing   Grosso Amie  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2303-2311

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety and tolerability of ezetimibe coadministered with simvastatin in hypercholesterolemic patients: a randomized, 12-month double-blind extension study

By Strony John   Yang Bo   Hanson Mary E.   Veltri Enrico P.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3149-3157

Informa Healthcare

Access to resources Recommend Favorite